Share on LinkedInShare on LinkedIn

ARTICLE · 02 DECEMBER 2021

Disclosure Obligations In The Covid-19 Era

Cassels
Cassels
Contributor
Cassels

Cassels

Cassels Brock & Blackwell LLP is a Canadian law firm focused on serving the transaction, advocacy,...

View firm profile
Explore more from Cassels

As the COVID-19 pandemic continues to cause considerable social and economic uncertainty, reporting issuers across all industries must remain diligent in disclosing the impacts of the pandemic...

CanadaCoronavirus (COVID-19)

As the COVID-19 pandemic continues to cause considerable social and economic uncertainty, reporting issuers across all industries must remain diligent in disclosing the impacts of the pandemic – whether realized or anticipated – on their business operations, current financial condition, liquidity, and future prospects. The Canadian Securities Administrators (CSA) has indicated that they are committed to closely monitoring potentially misleading disclosure related to COVID-19,1 but over a year and a half into the pandemic, no Canadian securities regulator has announced charges against any reporting issuers for improper COVID-19 disclosure.

The CSA has conducted studies throughout the COVID-19 pandemic to review disclosure filings and analyze issuers' compliance with National Instrument 51-102 Continuous Disclosure Obligations. Most recently, the CSA published CSA Staff Notice 51-362 (SN 51-362), which summarized their findings and offered guidance on improved

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from